These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 29344674)

  • 1. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
    Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
    Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
    Yu Q; Du Y; Wang S; Zheng X
    J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
    Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis.
    Yao Y; Liu Y; Jin F; Meng Z
    Yonsei Med J; 2021 Jul; 62(7):640-649. PubMed ID: 34164962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
    Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
    Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma.
    Zou S; Gao Y; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linc01234 promotes cell proliferation and metastasis in oral squamous cell carcinoma via miR-433/PAK4 axis.
    Liu D; Jian X; Xu P; Zhu R; Wang Y
    BMC Cancer; 2020 Feb; 20(1):107. PubMed ID: 32041570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
    Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK
    Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA‑198 suppresses tumour growth and metastasis in oral squamous cell carcinoma by targeting CDK4.
    Kang Y; Zhang Y; Sun Y
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
    Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
    Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells.
    Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH
    J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma.
    Zhu X; Zhang H; Xu J
    Bioengineered; 2021 Dec; 12(1):3993-4003. PubMed ID: 34282711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2.
    Tao D; Zhang Z; Liu X; Zhang Z; Fu Y; Zhang P; Yuan H; Liu L; Cheng J; Jiang H
    Mol Carcinog; 2020 Apr; 59(4):353-364. PubMed ID: 31995261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR‑144‑3p inhibits tumor cell growth and invasion in oral squamous cell carcinoma through the downregulation of the oncogenic gene, EZH2.
    He L; Liao L; Du L
    Int J Mol Med; 2020 Aug; 46(2):828-838. PubMed ID: 32626925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA highly up-regulated in liver cancer promotes epithelial-to-mesenchymal transition process in oral squamous cell carcinoma.
    Su W; Tang J; Wang Y; Sun S; Shen Y; Yang H
    J Cell Mol Med; 2019 Apr; 23(4):2645-2655. PubMed ID: 30677230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA NEAT1 promotes cell proliferation and invasion by regulating miR‑365/RGS20 in oral squamous cell carcinoma.
    Huang G; He X; Wei XL
    Oncol Rep; 2018 Apr; 39(4):1948-1956. PubMed ID: 29484420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.